Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|July 9, 2021
Patterns and Predictors of Failure in Recurrent or Refractory Large B-Cell Lymphomas After Chimeric Antigen Receptor T-Cell TherapyNicholas B Figura, Timothy J Robinson, Austin J Sim, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2019
Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell LymphomaAustin J Sim, Michael D Jain, Nicholas B Figura, et al.
Cytotherapy|September 29, 2025
Quality indicators for cell collections for immune effector cell and gene therapy: recommendations from the American Society for ApheresisNicole A Aqui, Patricia A Shi, Yara A Park, et al.
Blood Advances|July 24, 2020
High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphomaErin A Dean, Rahul S Mhaskar, Hong Lu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 24, 2017
Music Therapy for Symptom Management After Autologous Stem Cell Transplantation: Results From a Randomized StudyDebbie Bates, Brian Bolwell, Navneet S Majhail, et al.
Transplantation and Cellular Therapy|May 13, 2024
Autologous Hematopoietic Cell Transplantation Consolidation for First Response is Associated With Longer Survival Among Patients With Nodal Peripheral T Cell LymphomaYumeng Zhang, Ashley Rose, Sushmita Khadka, et al.
Transplantation and Cellular Therapy|March 29, 2026
Gene therapy for sickle cell disease: Practice recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene TherapyAkshay Sharma, Adetola Kassim, Alexis Thompson, et al.
Haematologica|April 25, 2020
Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphomaJennifer M Logue, Elisa Zucchetti, Christina A Bachmeier, et al.
Cancer Medicine|February 28, 2021
Acute patient-reported outcomes in B-cell malignancies treated with axicabtagene ciloleucelAasha I Hoogland, Reena V Jayani, Aaron Collier, et al.
Transplantation and Cellular Therapy|September 21, 2024
Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell TherapyAasha I Hoogland, Anna Barata, Xiaoyin Li, et al.
Pageof 3